Cargando…
Using historical data to facilitate clinical prevention trials in Alzheimer disease? An analysis of longitudinal MCI (mild cognitive impairment) data sets
BACKGROUND: The Placebo Group Simulation Approach (PGSA) aims at partially replacing randomized placebo-controlled trials (RPCTs), making use of data from historical control groups in order to decrease the needed number of study participants exposed to lengthy placebo treatment. PGSA algorithms to c...
Autores principales: | Berres, Manfred, Monsch, Andreas U., Spiegel, René |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106156/ https://www.ncbi.nlm.nih.gov/pubmed/33962665 http://dx.doi.org/10.1186/s13195-021-00832-5 |
Ejemplares similares
-
Establishing robust cognitive dimensions for characterization and differentiation of patients with Alzheimer's disease, mild cognitive impairment, frontotemporal dementia and depression
por: Beck, Irene R, et al.
Publicado: (2014) -
The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer’s Disease: The Temporal Emergence of Cognitive Decline
por: Mistridis, Panagiota, et al.
Publicado: (2015) -
For debate: substituting placebo controls in long-term Alzheimer's prevention trials
por: Spiegel, René, et al.
Publicado: (2011) -
Risk Factors for Mild Cognitive Impairment (MCI)
por: Loftus, Andrea Mary
Publicado: (2017) -
The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples
por: Thomann, Alessandra E., et al.
Publicado: (2018)